Societal value of lecanemab in Japan published in Neurology and Therapy ...Middle East

Stockholm, May 16, 2023 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today announced the publication of results from a simulation study evaluating the societal value of lecanemab (brand name in the U.S.: LEQEMBI™), an investigational anti-amyloid beta...

Hence then, the article about societal value of lecanemab in japan published in neurology and therapy was published today ( Wednesday 17/05/2023 - 06:28 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Societal value of lecanemab in Japan published in Neurology and Therapy )

Also on site :

• Travis County deputy arrested on official oppression charge
• 10 Shows Like 'Your Friends and Neighbors' You Should Watch Next
• Republicans Flirt With Kicking Americans Off Health Care to Fund Iran War